{"id":847953,"date":"2026-09-17T04:33:57","date_gmt":"2026-09-16T20:33:57","guid":{"rendered":"https:\/\/www.alphaseek.cn\/?p=847953"},"modified":"2026-09-17T04:33:57","modified_gmt":"2026-09-16T20:33:57","slug":"%e7%be%8e%e8%82%a1%e8%b7%8c%e5%b9%85%e6%a6%9c%e5%89%8d%e5%8d%81%ef%bc%8cxenetic-biosciences-inc-xbio-us%e8%b7%8c48-71%ef%bc%8ccuprina-holdings-cayman-limited-class-acupr-us%e8%b7%8c45-39","status":"publish","type":"post","link":"https:\/\/www.alphaseek.cn\/?p=847953","title":{"rendered":"\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cXenetic Biosciences, Inc.(XBIO.US)\u8dcc48.71%\uff0cCuprina Holdings (Cayman) Limited Class A(CUPR.US)\u8dcc45.39%"},"content":{"rendered":"
\n
\n
\n
\n

\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cXenetic Biosciences, Inc.(XBIO.US)\u8dcc48.71%\uff0cCuprina Holdings (Cayman) Limited Class A(CUPR.US)\u8dcc45.39%<\/h1>\n

<\/i><\/a> <\/div>\n

\n
\n
\u65e5\u671f\uff1a<\/span> 2026\u5e749\u670817\u65e5 \u4e0a\u53484:15<\/span> <\/div>\n<\/p><\/div>\n
<\/i><\/a><\/i><\/a><\/p>\n
<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n
<\/div>\n
\n

\u3010\u8ca1\u83ef\u793e\u8a0a\u3011\u5317\u4eac\u6642\u95932026\u5e749\u670817\u65e5\u6de9\u6668\uff0c\u7f8e\u80a1\u5468\u4e09\u6536\u76e4\uff0c\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\u540d\u5206\u5225\u70baXenetic Biosciences, Inc.(XBIO.US)\u8dcc\u5e4548.71%\u3001Cuprina Holdings (Cayman) Limited Class A(CUPR.US)\u8dcc\u5e4545.39%\u3001Myseum, Inc.(MYSE.US)\u8dcc\u5e4534.67%\u3001\u745e\u5716\u751f\u614b(RETO.US)\u8dcc\u5e4534.29%\u3001Cheetah Net Supply Chain Service, Inc. Class A(CTNT.US)\u8dcc\u5e4532.52%\u3001IPO<\/a>WER, Inc.(IPW.US)\u8dcc\u5e4530.80%\u3001Artelo Biosciences Inc(ARTL.US)\u8dcc\u5e4529.78%\u3001VisionWave Holdings, Inc.(VWAV.US)\u8dcc\u5e4529.15%\u3001Biodexa Pharmaceuticals plc Sponsored ADR(BDRX.US)\u8dcc\u5e4527.82%\u3001Merlin, Inc.(MRLN.US)\u8dcc\u5e4527.54%\u3002<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u5e8f\u865f<\/th>\n\u4ee3\u78bc<\/th>\n\u540d\u7a31<\/th>\n\u6f32\u8dcc\u5e45(%)<\/th>\n\u6700\u65b0\u50f9<\/th>\n<\/tr>\n<\/thead>\n
1<\/td>\nXBIO.US<\/td>\nXenetic Biosciences, Inc.<\/td>\n-48.71<\/td>\n2.190<\/td>\n<\/tr>\n
2<\/td>\nCUPR.US<\/td>\nCuprina Holdings (Cayman) Limited Class A<\/td>\n-45.39<\/td>\n1.600<\/td>\n<\/tr>\n
3<\/td>\nMYSE.US<\/td>\nMyseum, Inc.<\/td>\n-34.67<\/td>\n2.110<\/td>\n<\/tr>\n
4<\/td>\nRETO.US<\/td>\n\u745e\u5716\u751f\u614b<\/td>\n-34.29<\/td>\n1.840<\/td>\n<\/tr>\n
5<\/td>\nCTNT.US<\/td>\nCheetah Net Supply Chain Service, Inc. Class A<\/td>\n-32.52<\/td>\n0.042<\/td>\n<\/tr>\n
6<\/td>\nIPW.US<\/td>\nIPOWER, Inc.<\/td>\n-30.80<\/td>\n1.820<\/td>\n<\/tr>\n
7<\/td>\nARTL.US<\/td>\nArtelo Biosciences Inc<\/td>\n-29.78<\/td>\n3.750<\/td>\n<\/tr>\n
8<\/td>\nVWAV.US<\/td>\nVisionWave Holdings, Inc.<\/td>\n-29.15<\/td>\n0.377<\/td>\n<\/tr>\n
9<\/td>\nBDRX.US<\/td>\nBiodexa Pharmaceuticals plc Sponsored ADR<\/td>\n-27.82<\/td>\n0.960<\/td>\n<\/tr>\n
10<\/td>\nMRLN.US<\/td>\nMerlin, Inc.<\/td>\n-27.54<\/td>\n2.210<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

(\u6765\u6e90:\u8d22\u534e\u793e) <\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n

XBIO.US<\/a> CUPR.US<\/a> MYSE.US<\/a> RETO.US<\/a> CTNT.US<\/a> IPW.US<\/a> ARTL.US<\/a> VWAV.US<\/a> BDRX.US<\/a> MRLN.US<\/a> <\/div>\n
\n
\"\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cXenetic <\/a> <\/div>\n<\/div>\n
<\/div>\n
\n
\n

\u4e0a\u4e00\u7bc7\u65b0\u805e<\/h3>\n

\u77e5\u540d\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cJB Hunt\u904b\u8f38\u670d\u52d9(JBHT.US)\u8dcc11.83%\uff0cClear Secure, Inc. Class A(YOU.US)\u8dcc5.03%<\/a> <\/div>\n

\n

\u4e0b\u4e00\u7bc7\u65b0\u805e<\/h3>\n

\u4e2d\u6982\u80a1\u6f32\u5e45\u699c\u524d\u5341\uff0c\u7f9a\u7f8a\u63a7\u80a1(AEHL.US)\u6f32+78.68%\uff0c\u9053\u5143\u96c6\u5718(ZTG.US)\u6f32+75.33%<\/a> <\/div>\n<\/p><\/div>\n

\n

\u76f8\u95dc\u6587\u7ae0<\/h3>\n
\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u77e5\u540d\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cJB Hunt\u904b\u8f38\u670d\u52d9(JBHT.US)\u8dcc11.83%\uff0cClear Secure, Inc. Class A(YOU.US)\u8dcc5.03%<\/a><\/dd>\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u77e5\u540d\u7f8e\u80a1\u6f32\u5e45\u699c\u524d\u5341\uff0cIllumina, Inc.(ILMN.US)\u6f32+5.94%\uff0c\u82f1\u7279\u723e(INTC.US)\u6f32+5.45%<\/a><\/dd>\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u4e2d\u6982\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0c\u81f4\u4fdd\u79d1\u6280(ZBAO.US)\u8dcc15.71%\uff0c\u83ef\u8c0c\u79d1\u6280(HCAI.US)\u8dcc15.57%<\/a><\/dd>\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u4e2d\u6982\u80a1\u6f32\u5e45\u699c\u524d\u5341\uff0c\u9053\u5143\u96c6\u5718(ZTG.US)\u6f32+189.75%\uff0c\u745e\u5716\u751f\u614b(RETO.US)\u6f32+94.64%<\/a><\/dd>\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cCuprina Holdings (Cayman) Limited Class A(CUPR.US)\u8dcc49.15%\uff0cXenetic Biosciences, Inc.(XBIO.US)\u8dcc37.35%<\/a><\/dd>\n
6\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u7f8e\u80a1\u6f32\u5e45\u699c\u524d\u5341\uff0c\u9053\u5143\u96c6\u5718(ZTG.US)\u6f32+189.75%\uff0cDataMeds AI, Inc.(MEDS.US)\u6f32+175.31%<\/a><\/dd>\n
12\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u3010\u7570\u52d5\u80a1\u3011\u6e2f\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0c\u7f8e\u81fb\u96c6\u5718(01825.HK)\u8dcc36.88%\uff0c\u5fb7\u5408\u96c6\u5718(00368.HK)\u8dcc32.17%<\/a><\/dd>\n
12\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u3010\u7570\u52d5\u80a1\u3011\u6e2f\u80a1\u6f32\u5e45\u699c\u524d\u5341\uff0c\u715c\u69ae\u96c6\u5718(01536.HK)\u6f32+164.40%\uff0c\u6d77\u5cfd\u77f3\u6cb9\u5316\u5de5(00852.HK)\u6f32+98.80%<\/a><\/dd>\n
18\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u6052\u745e\u91ab\u85e5(01276.HK)\uff1a\u6ce8\u5c04\u7528\u745e\u5361\u897f\u55ae\u6297\u7372\u85e5\u7269\u81e8\u5e8a\u8a66\u9a57\u6279\u51c6\u901a\u77e5\u66f8<\/a><\/dd>\n
18\u5c0f\u6642\u524d
<\/span><\/dt>\n
\u3010\u7570\u52d5\u80a1\u3011\u6e2f\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0c\u7dad\u6e2f\u74b0\u4fdd\u79d1\u6280(01845.HK)\u8dcc23.92%\uff0c\u74b0\u79d1\u570b\u969b(00657.HK)\u8dcc15.79%<\/a><\/dd>\n<\/dl><\/div>\n","protected":false},"excerpt":{"rendered":"

\u7f8e\u80a1\u8dcc\u5e45\u699c\u524d\u5341\uff0cXenetic Biosciences, Inc.(XBIO.US)\u8dcc48.71%\uff0cCupri […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[258,57,71,95,78],"views":10,"_links":{"self":[{"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=\/wp\/v2\/posts\/847953"}],"collection":[{"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=847953"}],"version-history":[{"count":0,"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=\/wp\/v2\/posts\/847953\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=847953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=847953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.alphaseek.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=847953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}